Glucosamine Sulfate 500 mg
Natural health product licensed in Canada
- Other names
- GLS, GLS 500 mg, Glucosamine Sulfate
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80000082
- Status
- Active licence
- Licence date
- 21 September 2004
- Revision date
- 6 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- (M) non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Rice flour, Stéarate de magnésium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in maintaining healthy cartilage and/or joint health. Helps to relieve pain associated with osteoarthritis of the knee. Helps protect against the deterioration of cartilage and relieve joint pain associated with osteoarthritis. Helps relieve osteoarthritic joint pain. Helps to protect against the deterioration of cartilage and is a factor in maintaining healthy cartilage and joint health. Helps to relieve joint pain associated with osteoarthritis. Helps to protect against the deterioration of cartilage.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80000082
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.